In tests, the Lung EpiCheck blood test developed by Israel’s Nucleix (reported here previously) detected 85% of early stage lung cancers among smokers and ex-smokers with a high risk for developing the disease. On low-risk individuals, the accuracy increased to … Continue reading →

A team of Israeli (Weizmann Institute) and British scientists have devised a blood test that analyzes activity of three enzymes (OGG1, MPG and APE1) connected to DNA damage. They say it can “significantly improve current lung cancer risk prediction, assisting … Continue reading →

I reported previously (31st Dec) on Israel’s Savicell and its ImmunoBiopsy blood test for detecting early stage lung cancer. Savicell’s test checks for the metabolic reactions that the immune system produces when it detects and attacks a tumor. Experts say … Continue reading →

I reported previously (see here) on two Israeli startups developing blood tests for diagnosing early stage lung cancer.  Here is another – Savicell, achieving a 91% success rate. Early detection gives the patient a 50-80% recovery chance.  At late stage … Continue reading →

Israeli scientists from the Rehovot-based company Nucleix succeeded in developing a first of its kind blood test to diagnose lung cancer long before it spreads in the body, thus increasing the chance of survival. The test examines anomalies of the … Continue reading →

A trial of the PROphet blood test from Israel’s OncoHost (see here previously) has proved its accuracy and reliability in predicting the best treatment for metastatic non-small cell lung cancer (NSCLC) patients. OncoHost has received orders from 29 US cancer … Continue reading →

The UK National Health Service (NHS) is to trial the blood test from Israel’s OncoHost (see here previously) that predicts how well cancer patients will respond to immunotherapy treatment. Trials will focus on patients with advanced melanoma or non-small cell … Continue reading →

I reported on Israel’s Medial EarlySign previously (May 2015) when it was MedialCS and trialing its colon cancer early-warning algorithm (now called Colon Flag) with Israel’s Maccabi Health company. EarlySign is now designing and validating models for upper GI cancer, … Continue reading →